{
    "question": "Based on the provided evidence, answer the following question: A 51-year-old woman presents to your office with 2 weeks of fatigue and generalized weakness. She has a past medical history of diabetes, hypertension, and hyperlipidemia. She was recently diagnosed with rheumatoid arthritis and started on disease-modifying therapy. She states she has felt less able to do things she enjoys and feels guilty she can't play sports with her children. Review of systems is notable for the patient occasionally seeing a small amount of bright red blood on the toilet paper. Laboratory studies are ordered as seen below.\n\nHemoglobin: 12 g/dL\nHematocrit: 36%\nLeukocyte count: 7,700/mm^3 with normal differential\nPlatelet count: 207,000/mm^3\nMCV: 110 fL\n\nWhat is the most likely etiology of this patient's fatigue?. If there are multiple answers, separate them with commas. In your explanation, point out what is correct and incorrect in the evidence.",
    "content": {
        "source_1": "A 51-year-old woman with 2 weeks of fatigue and generalized weakness demonstrates macrocytosis with an MCV of 110 fL in the setting of only borderline-low hemoglobin (12 g/dL) and hematocrit (36%), a leukocyte count of 7,700/mm^3 with a normal differential, and a platelet count of 207,000/mm^3, indicating an isolated macrocytic process without leukopenia or thrombocytopenia. The review of systems notes only occasional small amounts of bright red blood on toilet paper, a pattern more consistent with minimal distal bleeding and not a sufficient explanation for macrocytosis; moreover, iron deficiency from such minor bleeding would typically yield microcytosis rather than an elevated MCV. In contrast, megaloblastic erythropoiesis due to cobalamin deficiency is well aligned with these indices and the symptom of reduced exercise tolerance. The recent diagnosis of rheumatoid arthritis further raises the pretest probability of an autoimmune basis for cobalamin deficiency (eg, pernicious anemia) within an autoimmune diathesis. Taken together, this pattern most parsimoniously supports cobalamin deficiency as the etiology of the patient’s fatigue. Vitamin B12 deficiency.",
        "source_2": "The patient’s presentation—2 weeks of fatigue and generalized weakness—coincides with macrocytic indices (MCV 110 fL) in the context of preserved leukocyte (7,700/mm^3 with normal differential) and platelet counts (207,000/mm^3) and only mild anemia (hemoglobin 12 g/dL, hematocrit 36%). This hematologic profile is characteristic of megaloblastic anemia from impaired DNA synthesis and nuclear maturation, which in adults is most commonly attributable to deficiency of either cobalamin or folate. The review of systems finding of occasional small amounts of bright red blood on toilet paper is not adequate to explain macrocytosis and would more typically be associated with microcytic iron deficiency if clinically significant. In this clinical context—particularly with recent initiation of disease-modifying therapy for rheumatoid arthritis that may perturb folate metabolism and an autoimmune milieu that can predispose to pernicious anemia—both nutrient deficiencies are biologically plausible and cannot be distinguished on the basis of the provided data alone. Vitamin B12 or folate deficiency.",
        "source_3": "Macrocytosis (MCV 110 fL) with relatively preserved leukocyte and platelet counts (7,700/mm^3 with normal differential and 207,000/mm^3, respectively) and only mild reductions in hemoglobin (12 g/dL) and hematocrit (36%) suggests a selective defect in erythroid nuclear maturation consistent with megaloblastic hematopoiesis. In adults, this syndrome most often reflects impaired one-carbon transfer reactions required for thymidylate and purine synthesis, due to deficiency of cobalamin or folate, leading to ineffective erythropoiesis and the clinical manifestation of fatigue over a short interval such as 2 weeks. The small amounts of bright red blood on toilet paper do not account for macrocytosis and would be expected to lower MCV if iron loss were clinically significant. Recent initiation of disease-modifying therapy for rheumatoid arthritis may further increase susceptibility to folate-related derangements, while autoimmune conditions can coexist with cobalamin deficiency, rendering both etiologies tenable within the megaloblastic framework suggested by these indices. B12 or Folate deficiency.",
        "source_4": "The temporal association between the onset of 2 weeks of fatigue and recent initiation of disease-modifying therapy for rheumatoid arthritis, together with macrocytosis (MCV 110 fL) and otherwise preserved leukocyte and platelet counts (7,700/mm^3 with normal differential; 207,000/mm^3), supports a drug-related inhibition of nucleotide synthesis as the proximate cause of ineffective erythropoiesis. Many disease-modifying antirheumatic drugs impair folate-dependent pathways of DNA synthesis (eg, antifolate or folate-antagonizing mechanisms), producing megaloblastic erythroid changes that manifest as macrocytosis and mild anemia (hemoglobin 12 g/dL, hematocrit 36%) with symptomatic fatigue shortly after therapy initiation. The occasional small amounts of bright red blood on toilet paper are insufficient to explain macrocytosis and would more typically cause microcytosis if clinically meaningful. In this setting, a pharmacologic effect on erythropoiesis most parsimoniously explains the laboratory and clinical phenotype. Medication-induced macrocytic anemia."
    }
}